Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
15.94
-0.62 (-3.74%)
Nov 13, 2026, 3:00 PM CST
Shanghai ZJ Bio-Tech Revenue
Shanghai ZJ Bio-Tech had revenue of 30.87M CNY in the quarter ending September 30, 2026, with 0.38% growth. This brings the company's total for the last twelve months to 118.64M, down -9.78% year-over-year. In the year 2025, Shanghai ZJ Bio-Tech had annual revenue of 124.82M, down -30.13%. That makes Shanghai ZJ Bio-Tech the 34,494th largest company in the world by revenue and 5,100th in China.
Revenue (ttm)
118.64M
Revenue Growth
-9.78%
P/S Ratio
22.97
Revenue / Employee
441.04K
Employees
269
Market Cap
2.73B
Revenue by Geography
- China 120.11M 96.2%
- Overseas 4.70M 3.8%
Fiscal year ended Dec 31, 2025 See the full Shanghai ZJ Bio-Tech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 124.82M | -53.83M | -30.13% |
| Dec 31, 2024 | 178.65M | -95.68M | -34.88% |
| Dec 31, 2023 | 274.33M | -2.05B | -88.21% |
| Dec 31, 2022 | 2.33B | 307.43M | 15.23% |
| Dec 31, 2021 | 2.02B | -33.31M | -1.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.72B |
| Guangdong Transtek Medical Electronics | 1.05B |
| Jiangsu Hanbon Science and Technology | 849.02M |
| Chison Medical Technologies | 443.67M |
| Jiangsu Canopus Wisdom Medical Technology | 433.55M |
| Tellgen | 393.84M |
| Nanjing Medlander Medical Technology | 382.77M |
| Shanghai General Healthy Information and Technology | 350.19M |